Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?
BACKGROUND
: The histidine triad nucleotide-binding protein 1, HINT1, hydrolyzes adenosine 5'-monophosphoramidate substrates such as AMP-morpholidate. The human HINT1 gene is located on chromosome 5q31.2, a region implicated in linkage studies of schizophrenia. HINT1 had been shown to have different expression in postmortem brains between schizophrenia patients and unaffected controls. It was also found to be associated with the dysregulation of postsynaptic dopamine transmission, thus suggesting a potential role in several neuropsychiatric diseases.


METHODS
: In this work, we studied 8 SNPs around the HINT1 gene region using the Irish study of high density schizophrenia families (ISHDSF, 1350 subjects and 273 pedigrees) and the Irish case control study of schizophrenia (ICCSS, 655 affected subjects and 626 controls). The expression level of HINT1 was compared between the postmortem brain cDNAs from schizophrenic patients and unaffected controls provided by the Stanley Medical Research Institute.


RESULTS
: We found nominally significant differences in allele frequencies in several SNPs for both ISHDSF and ICCSS samples in sex-stratified analyses. However, the sex effect differed between the two samples. In expression studies, no significant difference in expression was observed between patients and controls. However, significant interactions amongst sex, diagnosis and rs3864283 genotypes were observed.


CONCLUSIONS
: Data from both association and expression studies suggested that variants at HINT1 may be associated with schizophrenia and the associations may be sex-specific. However, the markers showing associations were in high LD to the SPEC2/PDZ-GEF2/ACSL6 locus reported previously in the same samples. This made it difficult to separate the association signals amongst these genes. Other independent studies may be necessary to distinguish these candidate genes.
Chen
Qi
Q
Department of Psychiatry and Virginia Institute for Psychiatric and Behavior Genetics, Virginia Commonwealth University, 800 E. Leigh Street, Richmond, VA 23298, United States.
Wang
Xu
X
O'Neill
Francis A
FA
Walsh
Dermot
D
Kendler
Kenneth S
KS
Chen
Xiangning
X
D000328:Adult; D016022:Case-Control Studies; D002874:Chromosome Mapping; D005260:Female; D015870:Gene Expression; D005787:Gene Frequency; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006801:Humans; D007494:Ireland / Q000208:ethnology; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012559:Schizophrenia / Q000235:genetics*; D044465:White People / Q000235:genetics
D005819:Genetic Markers; C063306:HINT1 protein, human; D009419:Nerve Tissue Proteins
Mol Psychiatry. 1997 Mar;2(2):148-55
9106240
Am J Hum Genet. 2003 Jul;73(1):34-48
12802786
Biol Psychiatry. 2006 Sep 15;60(6):534-7
16860780
Hum Hered. 2008;66(2):87-98
18382088
Mol Psychiatry. 2000 Nov;5(6):638-49
11126394
Nat Rev Neurosci. 2006 Jun;7(6):477-84
16688123
Clin Psychol Rev. 1998 Nov;18(7):795-819
9827322
PLoS Genet. 2008 Mar 07;4(3):e1000016
18369441
Exp Cell Res. 1998 Oct 10;244(1):26-32
9770345
Hum Mol Genet. 2006 Nov 15;15(22):3329-42
17030554
Am J Hum Genet. 2005 May;76(5):887-93
15789306
J Cell Sci. 2005 Jul 15;118(Pt 14):3117-29
16014379
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Mol Psychiatry. 2002;7(6):542-59
12140777
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
12883005
Am J Psychiatry. 2000 Mar;157(3):402-8
10698816
Curr Pharm Des. 2005;11(8):1017-30
15777251
Genome Res. 2007 Sep;17(9):1286-95
17693573
Mol Psychiatry. 2007 Jan;12(1):74-86
17043677
Curr Opin Psychiatry. 2006 Mar;19(2):158-64
16612196
Nat Genet. 2006 Aug;38(8):931-5
16823379
Neuropsychopharmacology. 2007 Aug;32(8):1774-82
17203012
Brain Res Mol Brain Res. 2005 Oct 3;139(2):212-6
15953657
Biotechniques. 2003 Mar;34(3):610-6, 618-20, 622 passim
12661166
Science. 2002 Jun 21;296(5576):2225-9
12029063
Eur J Hum Genet. 2006 Jun;14(6):669-80
16721403
Neurochem Res. 2004 Jun;29(6):1245-55
15176481
Cancer Res. 2007 May 15;67(10):4700-8
17510397
Schizophr Bull. 2005 Oct;31(4):800-5
16166606
Mol Biol Evol. 1995 Sep;12(5):921-7
7476138
Mol Psychiatry. 2007 Mar;12(3):273-82
17179997
Genet Epidemiol. 2000;19 Suppl 1:S36-42
11055368
Methods. 2001 Dec;25(4):402-8
11846609
Mol Psychiatry. 2008 Oct;13(10):930-8
17667962
Curr Opin Genet Dev. 2007 Oct;17(5):394-9
17904351
Mol Psychiatry. 2005 May;10(5):470-8
15452587
J Neural Transm Suppl. 2001;(61):347-59
11771757
Mol Psychiatry. 1997 Mar;2(2):156-60
9106241
Genet Anal. 1999 Feb;14(5-6):143-9
10084106
Schizophr Bull. 2005 Jul;31(3):613-7
16081509
Schizophr Res. 2002 Nov 1;58(1):11-20
12363385
Am J Hum Genet. 2000 Jul;67(1):146-54
10825280
Genet Epidemiol. 2003 Sep;25(2):115-21
12916020
Am J Hum Genet. 2002 Dec;71(6):1296-302
12402217